140
Participants
Start Date
October 29, 2019
Primary Completion Date
August 10, 2023
Study Completion Date
March 31, 2026
Benralizumab
30 mg/mL solution for injection in a single accessorized prefilled syringe (APFS) will be administered subcutaneously (SC)
Mepolizumab
3x100 mg vials of powder for solution for injection reconstituted into 3 separate 1 mL syringes for administration on each dosing occasion. Injection volume per syringe is 1 mL. Mepolizumab active solution will be administered subcutaneously (SC)
Placebo to Mepolizumab
Matching placebo: 0.9% sodium chloride, solutions for injection in 1mL syringes (3 syringes will be used on each dosing occasion). Injection volume per syringe is 1mL. Placebo to Mepolizumban will be administered subcutaneously (SC)
Placebo to Benralizumab
Matching placebo solution for injection in APFS, 1 mL fill volume. Placebo solution will be administered subcutaneously (SC)
Research Site, Brussels
Research Site, Brussels
Research Site, New York
Research Site, Torino
Research Site, Great Neck
Research Site, Cuneo
Research Site, Marseille
Research Site, Philadelphia
Research Site, Milan
Research Site, Milan
Research Site, Hamburg
Research Site, Dijon
Research Site, Lübeck
Research Site, Toulouse
Research Site, Montpellier
Research Site, Nantes
Research Site, Ann Arbor
Research Site, Florence
Research Site, Ramat Gan
Research Site, Kirchheim
Research Site, Paris
Research Site, Denison
Research Site, Paris
Research Site, Freiburg im Breisgau
Research Site, Napoli
Research Site, Denver
Research Site, Beersheba
Research Site, Albuquerque
Research Site, Jerusalem
Research Site, Suresnes
Research Site, Bamberg
Research Site, Seattle
Research Site, Tel Aviv
Research Site, Rehovot
Research Site, Ashkelon
Research Site, Rochester
Research Site, Calgary
Research Site, Hamilton
Research Site, Toronto
Research Site, Toronto
Research Site, Roma
Research Site, Chiba
Research Site, Kita-gun
Research Site, Sagamihara-shi
Research Site, Sendai
Research Site, Shinjuku-ku
Research Site, Cambridge
Research Site, Leicester
Research Site, London
Research Site, Portsmouth
Lead Sponsor
AstraZeneca
INDUSTRY